Sonnet BioTherapeutics Holdings, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2024 was $7.62M, a 98.6% increase year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $6.49M, a 69.1% decline from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $21M, a 423% increase from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.01M, a 90.6% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.49M -$14.5M -69.1% Oct 1, 2023 Sep 30, 2024 10-K 2024-12-17
2023 $21M +$17M +423% Oct 1, 2022 Sep 30, 2023 10-K 2024-12-17
2022 $4.01M -$38.8M -90.6% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-14
2021 $42.8M +$19.8M +86.2% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-15
2020 $23M +$19.7M +588% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2019 $3.34M +$1.23M +58% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-19
2018 $2.12M +$33.9K +1.63% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 $2.08M Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2014 $3.03M -$2.86M -48.6% Jan 1, 2014 Dec 31, 2014 10-K 2015-04-15
2013 $5.89M -$132K -2.18% Jan 1, 2013 Dec 31, 2013 10-K 2015-04-15
2012 $6.03M +$3.17M +111% Jan 1, 2012 Dec 31, 2012 10-K 2013-04-03
2011 $2.85M +$2.29M +412% Jan 1, 2011 Dec 31, 2011 10-K 2013-04-03
2010 $558K Jan 1, 2010 Dec 31, 2010 10-K/A 2012-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.